Novonesis Plant Biosolutions A/S: Financial statements 2018
CVR: 30919246
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
Novonesis Plant Biosolutions A/S (CVR 30919246) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 328,207,795 and a net result of DKK 11,647,481 compared with DKK 47,102,055 the year before. That is a decrease of 7.5% compared with the year before. The profit margin was 3.5%. Equity in the 2018 report amounted to DKK 713,177,790. The solvency ratio was 39.9%.
- Revenue
- DKK 328,207,795
- Gross Profit
- DKK 309,523,626
- Profit/Loss
- DKK 11,647,481
- Equity
- DKK 713,177,790
- Total Assets
- DKK 1,785,526,334
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 328.2M | 309.5M | 11.6M | 713.2M | - |
| 2017 | 354.9M | 359.8M | 47.1M | 847.5M | - |
| 2016 | 352.1M | 320.8M | -58.8M | 974.4M | - |
| 2015 | - | 365.9M | 83.7M | 1.4B | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
Novonesis Plant Biosolutions A/S has published its annual report for 2017. Revenue came to DKK 354,942,745, and the net result was DKK 47,102,055.
About Novonesis Plant Biosolutions A/S
Novonesis Plant Biosolutions A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 2007. The company is registered under the industry Leasing af intellektuelle ejendomsrettigheder og lignende produkter, dog ikke ophavsretsbeskyttede værker. The company was previously named NOVOZYMES BIOAG A/S and NOVOZYMES BIOLOGICALS HOLDING A/S. The management consists of Lisbet Kragelund. The board consists of Mikkel Viltoft (chair), Lisbet Kragelund and Rainer Chapour Lehmann. The company is owned by NOVOZYMES A/S. According to the 2022 annual report, the company had an average of 0 employees. In 2025, the company reported revenue of DKK 126,088,828 and a net result of DKK 520,581,561 compared with DKK 403,926,577 the year before. Equity in the 2025 report amounted to DKK 853,779,346.
